Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Rutgers University Clinical Research Center
2394
mi
from 98109
New Brunswick, NJ
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Rutgers University Clinical Research Center
2394
mi
from 98109
New Brunswick, NJ
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Hospital for Special Surgery
2402
mi
from 98109
New York, NY
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Hospital for Special Surgery
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
2024
mi
from 98109
Cleveland, OH
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Center at Houston
1892
mi
from 98109
Houston, TX
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Center at Houston
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
University of Utah
703
mi
from 98109
Salt Lake City, UT
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
University of Utah
703
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Swedish Health Services
2
mi
from 98109
Seattle, WA
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Swedish Health Services
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Arthritis Associates of Southern California
967
mi
from 98109
Los Angeles, CA
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Arthritis Associates of Southern California
967
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Columbia University
2400
mi
from 98109
New York, NY
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Columbia University
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
2134
mi
from 98109
Pittsburgh, PA
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
St. Joseph Health Care London
1998
mi
from 98109
London,
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
St. Joseph Health Care London
1998
mi
from 98109
London,
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Steffens Scleroderma Center
2353
mi
from 98109
Albany, NY
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Steffens Scleroderma Center
2353
mi
from 98109
Albany, NY
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Northwell Health
2412
mi
from 98109
Great Neck, NY
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Northwell Health
2412
mi
from 98109
Great Neck, NY
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Ohio State University Medical Center
2007
mi
from 98109
Columbus, OH
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Ohio State University Medical Center
2007
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Georgetown University
2322
mi
from 98109
Washington,
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Georgetown University
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Arkansas Children's Hospital
1782
mi
from 98109
Little Rock, AR
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Hospital
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Rady Children's Hospital
1060
mi
from 98109
San Diego, CA
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Rady Children's Hospital
1060
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Connecticut Children's Hospital
2429
mi
from 98109
Hartford, CT
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Connecticut Children's Hospital
2429
mi
from 98109
Hartford, CT
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Arnold Palmer Hospital for Children
2549
mi
from 98109
Orlando, FL
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Arnold Palmer Hospital for Children
2549
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Kapiolani Medical Center for Women and Children
147
mi
from 98109
Honolulu, HI
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Kapiolani Medical Center for Women and Children
147
mi
from 98109
Honolulu, HI
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Helen DeVos Children's Hospital
1794
mi
from 98109
Grand Rapids, MI
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Helen DeVos Children's Hospital
1794
mi
from 98109
Grand Rapids, MI
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital & Clinics of Minnesota
1392
mi
from 98109
Minneapolis, MN
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital & Clinics of Minnesota
1392
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospitals and Clinics
1503
mi
from 98109
Kansas City, MO
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospitals and Clinics
1503
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Levine Children's Hospital
2282
mi
from 98109
Charlotte, NC
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Levine Children's Hospital
2282
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Penn State Milton S. Hershey Medical Center and Children's Hospital
2293
mi
from 98109
Hershey, PA
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center and Children's Hospital
2293
mi
from 98109
Hershey, PA
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Monroe Carrell Jr Children's Hospital at Vanderbilt
1970
mi
from 98109
Nashville, TN
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Monroe Carrell Jr Children's Hospital at Vanderbilt
1970
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Dell Children's Blood and Cancer Center
mi
from 98109
Austin, TX
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Dell Children's Blood and Cancer Center
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Texas Children's Cancer and Hematology Centers
1890
mi
from 98109
Houston, TX
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Texas Children's Cancer and Hematology Centers
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Primary Children's Hospital
699
mi
from 98109
Salt Lake City, UT
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Primary Children's Hospital
699
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Cardinal Glennon Children's Medical Center
1719
mi
from 98109
Saint Louis, MO
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Cardinal Glennon Children's Medical Center
1719
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Randall Children's Hospital
146
mi
from 98109
Portland, OR
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Randall Children's Hospital
146
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
American University of Beirut Medical Center
6638
mi
from 98109
Beirut,
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
American University of Beirut Medical Center
6638
mi
from 98109
Beirut,
Click here to add this to my saved trials
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated:  12/31/1969
Children's Hospital at Montefiore
2403
mi
from 98109
Bronx, NY
Molecular-Guided Therapy for Childhood Cancer
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Status: Enrolling
Updated: 12/31/1969
Children's Hospital at Montefiore
2403
mi
from 98109
Bronx, NY
Click here to add this to my saved trials
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of California-Davis
627
mi
from 98109
Sacramento, CA
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of California-Davis
627
mi
from 98109
Sacramento, CA
Click here to add this to my saved trials
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Nemours Hospital
2547
mi
from 98109
Orlando, FL
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Nemours Hospital
2547
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Laurie Children's Hospital Of Chicago
1733
mi
from 98109
Chicago, IL
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Laurie Children's Hospital Of Chicago
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Washington University in Saint Louis
1718
mi
from 98109
Saint Louis, MO
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Washington University in Saint Louis
1718
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Research Institute Center for Gene Therapy at Nationwide Children's Hospital
2008
mi
from 98109
Columbus, OH
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Research Institute Center for Gene Therapy at Nationwide Children's Hospital
2008
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of Texas South Western Medical Center of Dallas
1680
mi
from 98109
Dallas, TX
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Phase 2 Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of Texas South Western Medical Center of Dallas
1680
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
St Joseph's Hospital/Barrow Neurological Institute
1116
mi
from 98109
Phoenix, AZ
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
St Joseph's Hospital/Barrow Neurological Institute
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
Stanford University Medical Center
708
mi
from 98109
Palo Alto, CA
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
Stanford University Medical Center
708
mi
from 98109
Palo Alto, CA
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
San Francisco General Hospital
683
mi
from 98109
San Francisco, CA
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
San Francisco General Hospital
683
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital
2432
mi
from 98109
New Haven, CT
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
University of Florida
2461
mi
from 98109
Jacksonville, FL
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
University of Florida
2461
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
Loyola University Medical Center
1724
mi
from 98109
Chicago, IL
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
Loyola University Medical Center
1724
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials